GB0423273D0 - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
GB0423273D0
GB0423273D0 GBGB0423273.2A GB0423273A GB0423273D0 GB 0423273 D0 GB0423273 D0 GB 0423273D0 GB 0423273 A GB0423273 A GB 0423273A GB 0423273 D0 GB0423273 D0 GB 0423273D0
Authority
GB
United Kingdom
Prior art keywords
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0423273.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manchester filed Critical University of Manchester
Priority to GBGB0423273.2A priority Critical patent/GB0423273D0/en
Publication of GB0423273D0 publication Critical patent/GB0423273D0/en
Priority to CA002626774A priority patent/CA2626774A1/en
Priority to US11/577,658 priority patent/US20080096793A1/en
Priority to PCT/GB2005/003940 priority patent/WO2006043031A2/en
Priority to JP2007537367A priority patent/JP2008517045A/ja
Priority to EP05799897A priority patent/EP1809314A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0423273.2A 2004-10-20 2004-10-20 Treatment of cancer Ceased GB0423273D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0423273.2A GB0423273D0 (en) 2004-10-20 2004-10-20 Treatment of cancer
CA002626774A CA2626774A1 (en) 2004-10-20 2005-10-13 Class iii slrp for the treatment of cancer
US11/577,658 US20080096793A1 (en) 2004-10-20 2005-10-13 Class III Slrp for the Treatment of Cancer
PCT/GB2005/003940 WO2006043031A2 (en) 2004-10-20 2005-10-13 Class iii slrp for the treatment of cancer
JP2007537367A JP2008517045A (ja) 2004-10-20 2005-10-13 癌の治療法
EP05799897A EP1809314A2 (en) 2004-10-20 2005-10-13 Class iii slrp for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0423273.2A GB0423273D0 (en) 2004-10-20 2004-10-20 Treatment of cancer

Publications (1)

Publication Number Publication Date
GB0423273D0 true GB0423273D0 (en) 2004-11-24

Family

ID=33484868

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0423273.2A Ceased GB0423273D0 (en) 2004-10-20 2004-10-20 Treatment of cancer

Country Status (6)

Country Link
US (1) US20080096793A1 (enExample)
EP (1) EP1809314A2 (enExample)
JP (1) JP2008517045A (enExample)
CA (1) CA2626774A1 (enExample)
GB (1) GB0423273D0 (enExample)
WO (1) WO2006043031A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004105784A1 (en) * 2003-05-29 2004-12-09 The University Of Manchester Class iii slrp agonists for the reduction of blood vessel formation
CN102549436A (zh) 2009-07-27 2012-07-04 霍夫曼-拉罗奇有限公司 mimecan在评价心力衰竭中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827702A (en) * 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
DE4445630A1 (de) * 1994-12-21 1996-06-27 Forssmann Wolf Georg Humane zirkulierende Peptidfragmente 20-92 und 23-74 des Precursor des Osteoinduktiven Faktors kurz: OIF-20-92 und OIF 23-74
AU5593398A (en) * 1996-12-05 1998-06-29 Alcon Laboratories, Inc. The use of inhibitors of tgf-beta's functions to ameliorate ocular pathology
WO2000068264A2 (en) * 1999-05-10 2000-11-16 The Texas A & M University System A peptide inhibitor of fibrinogen blood clotting
US7304137B2 (en) * 2001-12-13 2007-12-04 The Texas A & M University System Nucleotide and amino acid sequences of asporins
WO2004105784A1 (en) * 2003-05-29 2004-12-09 The University Of Manchester Class iii slrp agonists for the reduction of blood vessel formation

Also Published As

Publication number Publication date
JP2008517045A (ja) 2008-05-22
WO2006043031A2 (en) 2006-04-27
WO2006043031A3 (en) 2006-07-06
US20080096793A1 (en) 2008-04-24
EP1809314A2 (en) 2007-07-25
CA2626774A1 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
IL188746A0 (en) Treatment of cancer
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
IL188430A0 (en) Treatment of tumors
IL180729A0 (en) Compounds and methods for treatment of cancer
EP1968607A4 (en) TREATMENT OF CANCER AND OTHER DISEASES
IL197315A0 (en) Treatment of cancer
EP1830847A4 (en) ANTICANCER TREATMENT
EP1755394A4 (en) METHOD OF TREATING CANCER
GB0428187D0 (en) Cancer treatment
IL161899A0 (en) Kit for treatment of cancer
EP1765344A4 (en) CANCER TREATMENT METHOD
GB0413346D0 (en) Treating cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0426196D0 (en) Methods of treatment
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
GB0329416D0 (en) Treatment of cancer
GB0520067D0 (en) Treatment of cancer
GB0410379D0 (en) Treatment of cancer
IL180709A0 (en) Treatment of tumours
GB0423273D0 (en) Treatment of cancer
GB0404675D0 (en) Cancer treatment
GB0421734D0 (en) Treatment of cancer
IL180460A0 (en) Treatment of cancer
GB0422225D0 (en) Treatment of cancer
ZA200700845B (en) Treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)